| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Journal of Clinical Microbiology, April 2007, p. 1319-1321, Vol. 45, No. 4
0095-1137/07/$08.00+0 doi:10.1128/JCM.01818-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Laboratoire de Virologie Hôpital Robert Debré, IFR 53/EA-3798, CHU et Faculté de Médecine de Reims, Reims, France,1 Laboratoire d'Immunologie Hôpital Robert Debré, IFR 53/EA-3798, CHU et Faculté de Médecine de Reims, Reims, France2
Received 1 September 2006/ Returned for modification 26 November 2006/ Accepted 13 January 2007
We assessed the genetic and the antigenic variability within the env gene of peripheral blood human immunodeficiency virus (HIV) type 1 (HIV-1) group O populations during the natural course of a female heterosexual infection. Our data revealed the existence of a significant increase in amino acid sequence variability within the C2-V3 and gp41 regions (P = 0.023 and P < 0.001, respectively) in association with substitutions within neutralizing epitope sequences usually selected for HIV serological assays. These antigenic variations might significantly decrease the sensitivity of classical HIV enzyme-linked immunosorbent assays with blood samples of subjects heterosexually infected by HIV-1 group O strains. These findings may be of significant use both to devise diagnostic tools and to pursue suitable therapeutic modalities in cases of heterosexual infection by outlier HIV-1 strains.
Published ahead of print on 31 January 2007.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|